Delivery Order SPE2DX22D0010-SPE2D826FBM07
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,139.22 to AmerisourceBergen Drug Corp for 27mg Concerta ER tablets on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with the Defense Logistics Agency. The pharmaceutical products will be delivered to the vendor's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Concerta ER Tablets 18mg, with a ceiling value of $1,588.38. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta 54mg tablets (100-count units) valued at $12,350.28 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $13,437.60 to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 36mg. This competitively awarded, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement action. This...
- The Defense Department's Medical Supply Chain awarded a $48,919.58 delivery order to AmerisourceBergen Drug Corp for Concerta ER tablets 27mg, with an ultimate completion date of October 3, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $44,675.27 to AmerisourceBergen Drug Corp for the supply of Concerta HCL 18mg tablets (100 count) on July 31, 2025. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Concerta ER (extended-release) 27 mg tablets. This competitively awarded, firm fixed-price delivery order has a ceiling value of approximately $24.9K and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a delivery order, this contract is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Concerta ER 36 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $3,836.73 and an ultimate completion date of July 15, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $2,986.52. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award reflecting the vendor's capability to meet federal pharmaceutical procurement requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBM07Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $2,101.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Concerta ER (extended-release) tablets at 18mg strength. This non-competitive delivery order, issued on December 3, 2025, with completion targeted for December 4, 2025, represents a small-value pharmaceutical procurement for military healthcare needs. The award was made to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered as a major pharmaceutical distributor serving federal medical systems. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide. The arrangement reflects the company's established role as a critical vendor for the Defense Health Agency and other federal healthcare systems, with the capability to fulfill routine medication deliveries such as this Concerta order through an established pricing and delivery mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/2/25 |